1 – 10 of 180
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
(
- Contribution to journal › Article
-
Mark
Validation of IgA nephropathy diagnosis in the Swedish Renal Registry
(
- Contribution to journal › Article
-
Mark
Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment
2024) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 39(1). p.45-54(
- Contribution to journal › Article
-
Mark
A population-based study on the incidence and aetiology of infectious complications in peritoneal dialysis in South Sweden
(
- Contribution to journal › Article
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
(
- Contribution to journal › Article
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
2024) p.191-191(
- Contribution to conference › Abstract
-
Mark
Imlifidase in kidney transplantation
(
- Contribution to journal › Scientific review
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article